Effect of adenosine, adenosine triphosphate, adenosine deaminase, dipyridamole and aminophylline on acetylcholine release from electrically-stimulated brain slices.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 6877538)

Published in Neuropharmacology on May 01, 1983

Authors

F Pedata, T Antonelli, L Lambertini, L Beani, G Pepeu

Articles by these authors

Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63

Vagal non-adrenergic inhibition of guinea-pig stomach. J Physiol (1971) 2.29

The effect of catecholamines and sympathetic stimulation on the release of acetylcholine from the guinea-pig colon. Br J Pharmacol (1969) 1.81

Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats. Neuroscience (2001) 1.50

Pharmacokinetics and efficacy of ropivacaine continuous wound instillation after joint replacement surgery. Br J Anaesth (2003) 1.49

Noradrenaline inhibition of acetylcholine release from guinea-pig brain. Eur J Pharmacol (1978) 1.30

Further evidence for the presence of non-adrenergic inhibitory structures in the guinea-pig colon. Eur J Pharmacol (1968) 1.26

Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol (1984) 1.19

The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology (1999) 1.17

Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol (1999) 1.16

Effects of metoclopramide on isolated guinea-pig colon. 2. Interference with ganglionic stimulant drugs. Eur J Pharmacol (1970) 1.16

Effect of psychoactive drugs on the output of acetylcholine from the cerebral cortex of the cat. Eur J Pharmacol (1968) 1.15

Investigations into the acetylcholine output from the cerebral cortex of the cat in the presence of hyoscine. Br J Pharmacol Chemother (1967) 1.15

Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease. Neuroscience (2005) 1.14

The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci Lett (1998) 1.12

Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav (1996) 1.11

On status badges and quality signals in the paper wasp Polistes dominulus: body size, facial colour patterns and hierarchical rank. Proc Biol Sci (2008) 1.10

Tiny genomes and endoreduplication in Strepsiptera. Insect Mol Biol (2004) 1.09

Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol (1998) 1.07

Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats. Br J Pharmacol (1996) 1.06

Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage. Stroke (1999) 1.05

The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol (1996) 1.04

The cerebral acetylcholine release in conscious rabbits with semi-permanently implanted epidural cups. Int J Neuropharmacol (1968) 1.03

Investigation on acetylcholine, aspartate, glutamate and GABA extracellular levels from ventral hippocampus during repeated exploratory activity in the rat. Neurochem Res (2003) 1.03

Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol Psychiatry (1997) 1.02

Effects of morphine on brain and spinal acetylcholine levels and nociceptive threshold in the frog. Brain Res (1974) 1.02

Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease. Neuroscience (1999) 1.01

Taurine distribution in cat brain. J Neurochem (1972) 1.00

Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J Neurochem (1993) 0.99

Regional changes of acetylcholine and choline acetylase activity in the guinea-pig's brain after scopolamine. Experientia (1964) 0.99

The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. Neuroreport (1997) 0.99

Enhanced acetylcholine release in the hippocampus and cortex during acquisition of an operant behavior. Brain Res (1996) 0.99

Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors. Int J Immunopathol Pharmacol (2003) 0.99

Effects of selenium source and level of supplementation on the performance and meat quality of lambs. Meat Sci (2008) 0.98

The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. Neuroscience (2003) 0.98

The effect of naloxone on opioid-induced inhibition and facilitation of acetylcholine release in brain slices. Br J Pharmacol (1982) 0.97

Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats. Neuroscience (1997) 0.95

The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. J Neurosci (1998) 0.95

Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices. Br J Pharmacol (1999) 0.94

Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study. Neurochem Res (2004) 0.94

A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system. Gen Pharmacol (1996) 0.94

Oxiracetam prevents electroshock-induced decrease in brain acetylcholine and amnesia. Eur J Pharmacol (1986) 0.94

Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin. Br J Pharmacol (2000) 0.94

Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. Brain Res Bull (1986) 0.93

The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study. Cereb Cortex (2001) 0.93

A1 and A2 adenosine receptors modulate acetylcholine release from brain slices. Eur J Pharmacol (1984) 0.92

5-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs. Br J Pharmacol (1990) 0.92

Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions. Brain Res (1998) 0.92

Electrical stimulation of the stratum radiatum increases the release and neosynthesis of aspartate, glutamate, and gamma-aminobutyric acid in rat hippocampal slices. J Neurochem (1983) 0.92

Regional differences in the electrically stimulated release of endogenous and radioactive adenosine and purine derivatives from rat brain slices. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.92

Effect of bicuculline and strychnine on the acetylcholine content of the amphibian spinal cord. Br J Pharmacol (1972) 0.92

Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis. Neuroscience (1995) 0.91

Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins. Eur J Pharmacol (1995) 0.91

The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor. Neurosci Lett (1996) 0.91

Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil. Neuropharmacology (2000) 0.91

NO synthesis inhibition decreases cortical ACh release and impairs retention of a conditioned response. Brain Res (2001) 0.91

Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow. Neurobiol Dis (2004) 0.90

Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease. Parkinsonism Relat Disord (2004) 0.90

Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience (1992) 0.90

Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. Neurobiol Aging (1988) 0.90

Fidia and neuroscience. Nature (1993) 0.90

Different approaches to study acetylcholine release: endogenous ACh versus tritium efflux. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.89

Effect of magnocellular forebrain nuclei lesions on acetylcholine output from the cerebral cortex, electrocorticogram and behaviour. Arch Ital Biol (1982) 0.89

Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br J Pharmacol (1999) 0.89

Structural proteins of a human papovavirus (BK virus): a comparison with the structural proteins of simian virus 40. Virology (1975) 0.89

Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Res (1999) 0.89

Tacrine administration enhances extracellular acetylcholine in vivo and restores the cognitive impairment in aged rats. Pharmacol Res (1997) 0.89

GABA induced changes in acetylcholine release from slices of guinea-pig brain. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.88

Reciprocal dopamine-glutamate modulation of release in the basal ganglia. Neurochem Int (1998) 0.88

Adenosine and memory storage: effect of A(1) and A(2) receptor antagonists. Psychopharmacology (Berl) (1999) 0.88

Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res (1994) 0.88

Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2. Neurochem Int (2008) 0.88

Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels. J Neurosci Res (2001) 0.88

The release of acetylcholine from the brain: an approach to the study of the central cholinergic mechanisms. Prog Neurobiol (1973) 0.88

Muscarinic receptor modulation of acetylcholine release from rat cerebral cortex and hippocampus. Neurosci Lett (1995) 0.88

Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. Eur J Neurosci (2000) 0.87

Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. Br J Pharmacol (1991) 0.87

Effects of novelty, pain and stress on hippocampal extracellular acetylcholine levels in male rats. Brain Res (1997) 0.86

Effects of loading methods on rabbit welfare and meat quality. Meat Sci (2009) 0.86

Investigations into the relationship between phospholipids and brain acetylcholine. Adv Exp Med Biol (1976) 0.86

NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study. J Neurosci (1994) 0.86

Scopolamine induced changes of brain acetylcholine and EEG pattern in cats with complete pontine transection. Arch Ital Biol (1966) 0.86

Beta(1-40) amyloid peptide injection into the nucleus basalis of rats induces microglia reaction and enhances cortical gamma-aminobutyric acid release in vivo. Brain Res (1999) 0.85

Interactions among adenosine deaminase, adenosine A(1) receptors and dopamine D(1) receptors in stably cotransfected fibroblast cells and neurons. Neuroscience (2002) 0.85

Dopamine modulation of acetylcholine release from the guinea-pig brain. Eur J Pharmacol (1979) 0.85

Cortical acetylcholine release is increased and gamma-aminobutyric acid outflow is reduced during morphine withdrawal. Br J Pharmacol (1986) 0.85

NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms. J Neurochem (1998) 0.85

Acetylcholine input from the cerebral cortex, choline uptake and muscarinic receptors in morphine-dependent, freely-moving rats. Neuropharmacology (1980) 0.85

Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats. J Neural Transm (Vienna) (2002) 0.85

The influence of 5-hydroxytryptamine on the release of acetylcholine from guinea-pig brain ex vivo and in vitro. Neuropharmacology (1986) 0.85

Characterization of glutamate and [3H]D-aspartate outflow from various in vitro preparations of the rat hippocampus. Neurochem Int (1997) 0.85

Reversal by 3,4-dihydroxyphenylalanine of reserpine-induced regional changes in acetylcholine content in guinea-pig brain. Biochem Pharmacol (1966) 0.85

Stimulation by morphine of acetylcholine output from the cerebral cortex of septal rats. Brain Res (1975) 0.85